Skip to main content
Medical information Clinical review pending

Genetic Testing

QF PCR Any One Marker

The QF PCR Any One Marker test is a genetic test used to detect specific genetic abnormalities in prenatal samples, aiding in early diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Amniotic fluid, Chorionic Villus Sampling (CVS) tissue, or Cord blood. Confirm specific sample type required with the laboratory before booking.
Results
Results are typically available within 1-2 days. Confirm exact turnaround time with the laboratory before booking.
Preparation
A doctor's prescription is required for this test. Please consult your physician regarding any specific preparation needed before sample collection.
Test priceKSh 9,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the QF PCR Any One Marker test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Prenatal screening for specific genetic abnormalities
  • ✓Expectant mothers with a family history of genetic disorders
  • ✓Individuals exhibiting symptoms suggestive of genetic abnormalities
  • ✓Patients requiring genetic testing for travel purposes
  • ✓Confirmation of suspected genetic conditions
02

In plain language

What this test helps you understand

This test helps identify specific genetic abnormalities in prenatal samples, allowing for early diagnosis and informed medical management during pregnancy.
The QF PCR Any One Marker test is an advanced diagnostic tool designed to detect genetic abnormalities in prenatal samples. This test is particularly vital for expectant mothers, as it aids in the early identification of potential genetic disorders. By analyzing samples such as amniotic fluid, chorionic villi, or cord blood, healthcare providers can offer timely interventions that may significantly improve health outcomes for both the mother and the baby. This test specifically measures the presence of genetic markers associated with various conditions. Utilizing the Sanger Sequencing method, the QF PCR Any One Marker test can accurately identify specific genetic abnormalities, providing critical information for further medical management. Early detection of genetic disorders allows for proactive healthcare management and provides peace of mind for expectant parents. Results are typically available within 1-2 days. It is important to discuss the results with your healthcare provider, who can provide insights into what the findings mean for your health and the health of your baby.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA doctor's prescription is required for this test. Please consult your physician regarding any specific preparation needed before sample collection.
SampleAmniotic fluid, Chorionic Villus Sampling (CVS) tissue, or Cord blood. Confirm specific sample type required with the laboratory before booking.
MethodologyQuantitative Fluorescence Polymerase Chain Reaction (QF PCR) using Sanger Sequencing.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects specific genetic markers and may not identify all possible genetic abnormalities. It is not a comprehensive genetic screening test. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This is a genetic test used to detect specific genetic abnormalities in prenatal samples like amniotic fluid or CVS tissue.
Expectant mothers, especially those with a family history of genetic disorders, or individuals with symptoms suggesting a genetic condition may be advised to take this test.
Yes, a doctor's prescription is required to perform this test.
Results are typically available within 1-2 days, but please confirm the exact turnaround time with the laboratory.
The test measures the presence of specific genetic markers associated with certain conditions.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp